589 related articles for article (PubMed ID: 20154452)
21. The structural pathology for hypophosphatasia caused by malfunctional tissue non-specific alkaline phosphatase.
Yu Y; Rong K; Yao D; Zhang Q; Cao X; Rao B; Xia Y; Lu Y; Shen Y; Yao Y; Xu H; Ma P; Cao Y; Qin A
Nat Commun; 2023 Jul; 14(1):4048. PubMed ID: 37422472
[TBL] [Abstract][Full Text] [Related]
22. Improvement of the skeletal and dental hypophosphatasia phenotype in Alpl-/- mice by administration of soluble (non-targeted) chimeric alkaline phosphatase.
Gasque KC; Foster BL; Kuss P; Yadav MC; Liu J; Kiffer-Moreira T; van Elsas A; Hatch N; Somerman MJ; Millán JL
Bone; 2015 Mar; 72():137-47. PubMed ID: 25433339
[TBL] [Abstract][Full Text] [Related]
23. Enzyme replacement for craniofacial skeletal defects and craniosynostosis in murine hypophosphatasia.
Liu J; Campbell C; Nam HK; Caron A; Yadav MC; Millán JL; Hatch NE
Bone; 2015 Sep; 78():203-11. PubMed ID: 25959417
[TBL] [Abstract][Full Text] [Related]
24. Multisystemic functions of alkaline phosphatases.
Buchet R; Millán JL; Magne D
Methods Mol Biol; 2013; 1053():27-51. PubMed ID: 23860646
[TBL] [Abstract][Full Text] [Related]
25. Tissue-Nonspecific Alkaline Phosphatase-A Gatekeeper of Physiological Conditions in Health and a Modulator of Biological Environments in Disease.
Liedtke D; Hofmann C; Jakob F; Klopocki E; Graser S
Biomolecules; 2020 Dec; 10(12):. PubMed ID: 33302551
[TBL] [Abstract][Full Text] [Related]
26. In vivo overexpression of tissue-nonspecific alkaline phosphatase increases skeletal mineralization and affects the phosphorylation status of osteopontin.
Narisawa S; Yadav MC; Millán JL
J Bone Miner Res; 2013 Jul; 28(7):1587-98. PubMed ID: 23427088
[TBL] [Abstract][Full Text] [Related]
27. Physiological role of alkaline phosphatase explored in hypophosphatasia.
Whyte MP
Ann N Y Acad Sci; 2010 Mar; 1192():190-200. PubMed ID: 20392236
[TBL] [Abstract][Full Text] [Related]
28. Genetically Modified Mice for Studying TNAP Function.
Narisawa S
Subcell Biochem; 2015; 76():45-57. PubMed ID: 26219706
[TBL] [Abstract][Full Text] [Related]
29. Effect of the presence of cholesterol in the interfacial microenvironment on the modulation of the alkaline phosphatase activity during in vitro mineralization.
Favarin BZ; Andrade MAR; Bolean M; Simão AMS; Ramos AP; Hoylaerts MF; Millán JL; Ciancaglini P
Colloids Surf B Biointerfaces; 2017 Jul; 155():466-476. PubMed ID: 28472750
[TBL] [Abstract][Full Text] [Related]
30. Annexins A2, A6 and Fetuin-A Affect the Process of Mineralization in Vesicles Derived from Human Osteoblastic hFOB 1.19 and Osteosarcoma Saos-2 Cells.
Bozycki L; Mroczek J; Bessueille L; Mebarek S; Buchet R; Pikula S; Strzelecka-Kiliszek A
Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33924370
[TBL] [Abstract][Full Text] [Related]
31. Impaired calcification around matrix vesicles of growth plate and bone in alkaline phosphatase-deficient mice.
Anderson HC; Sipe JB; Hessle L; Dhanyamraju R; Atti E; Camacho NP; Millán JL; Dhamyamraju R
Am J Pathol; 2004 Mar; 164(3):841-7. PubMed ID: 14982838
[TBL] [Abstract][Full Text] [Related]
32. Functional assay of the mutant tissue-nonspecific alkaline phosphatase gene using U2OS osteoblast-like cells.
Orimo H; Goseki-Sone M; Hosoi T; Shimada T
Mol Genet Metab; 2008 Jul; 94(3):375-81. PubMed ID: 18455459
[TBL] [Abstract][Full Text] [Related]
33. Elevated skeletal osteopontin levels contribute to the hypophosphatasia phenotype in Akp2(-/-) mice.
Harmey D; Johnson KA; Zelken J; Camacho NP; Hoylaerts MF; Noda M; Terkeltaub R; Millán JL
J Bone Miner Res; 2006 Sep; 21(9):1377-86. PubMed ID: 16939396
[TBL] [Abstract][Full Text] [Related]
34. Basic fibroblast growth factor regulates phosphate/pyrophosphate regulatory genes in stem cells isolated from human exfoliated deciduous teeth.
Nowwarote N; Sukarawan W; Pavasant P; Foster BL; Osathanon T
Stem Cell Res Ther; 2018 Dec; 9(1):345. PubMed ID: 30526676
[TBL] [Abstract][Full Text] [Related]
35. A new perspective on the function of Tissue Non-Specific Alkaline Phosphatase: from bone mineralization to intra-cellular lipid accumulation.
Bartlett CL; Cave EM; Crowther NJ; Ferris WF
Mol Cell Biochem; 2022 Aug; 477(8):2093-2106. PubMed ID: 35471716
[TBL] [Abstract][Full Text] [Related]
36. Hypophosphatasia and the extracellular metabolism of inorganic pyrophosphate: clinical and laboratory aspects.
Caswell AM; Whyte MP; Russell RG
Crit Rev Clin Lab Sci; 1991; 28(3):175-232. PubMed ID: 1647780
[TBL] [Abstract][Full Text] [Related]
37. Lipid microenvironment affects the ability of proteoliposomes harboring TNAP to induce mineralization without nucleators.
Simão AMS; Bolean M; Favarin BZ; Veschi EA; Tovani CB; Ramos AP; Bottini M; Buchet R; Millán JL; Ciancaglini P
J Bone Miner Metab; 2019 Jul; 37(4):607-613. PubMed ID: 30324534
[TBL] [Abstract][Full Text] [Related]
38. Pharmacological TNAP inhibition efficiently inhibits arterial media calcification in a warfarin rat model but deserves careful consideration of potential physiological bone formation/mineralization impairment.
Opdebeeck B; Neven E; Millán JL; Pinkerton AB; D'Haese PC; Verhulst A
Bone; 2020 Aug; 137():115392. PubMed ID: 32360899
[TBL] [Abstract][Full Text] [Related]
39. Alkaline Phosphatase and Hypophosphatasia.
Millán JL; Whyte MP
Calcif Tissue Int; 2016 Apr; 98(4):398-416. PubMed ID: 26590809
[TBL] [Abstract][Full Text] [Related]
40. Apigenin Modulates AnxA6- and TNAP-Mediated Osteoblast Mineralization.
Mroczek J; Pikula S; Suski S; Weremiejczyk L; Biesaga M; Strzelecka-Kiliszek A
Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36361965
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
